OMCL
NASDAQ
$45.22
Omnicell Inc (OMCL)
Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
Sector:
Healthcare
Industry:
Health Information Services
Buy
Target: $61.29 (+35.54%)
Market Cap
$2.13B
Forward P/E
29.50
P/E Ratio
104.52
Free Cash Flow Yield
5.36%
Price Chart
Valuation
Market Cap$2.13B
P/E104.52
Forward P/E29.50
PEG15.40
P/S1.71
P/B1.69
Profitability
Total Revenue (TTM)$1.23B
Gross Profit (TTM)$537M
EBITDA$111M
Profit Margin3.7%
Operating Margin5.4%
EPS$0.45
Financial Health
Free Cash Flow Yield5.36%
Growth & Risk
EPS 5Y CAGR-11.34%
Revenue 5Y CAGR+6.02%
FCF 5Y CAGR-9.99%
Beta (5Y)0.85
Sharpe Ratio1.16